May 5 - Ann Arbor, MI - In the first study of the effects of statins on the concentrations of both low-density lipoprotein cholesterol (LDL-C; known as the "bad" cholesterol) and low-density lipoprotein particles (LDL-P) in patients with metabolic syndrome, it was shown that even though the statins lowered the concentrations of LDL-C to target levels, the patients retained considerable residual risk for cardiovascular events because LDL-P concentrations were not reduced to a similar extent. A pre-print version of the study in Diabetes Care is available online at http://dx.doi.org/10.2337/dc08-1681, and the final version will be available in print in the June 2009 issue, as well as online at the same URL.
High percentages of endocrinologists, primary care physicians, and managed care organizations surveyed by a research firm say they would like to see additional GLP-1 analogues like Amylin/Eli Lilly's Byetta® and DPP-IV inhibitors like Merck's Januvia® available to treat type 2 diabetes.
Of all the quests that researchers have undertaken in search of a cure or decisive treatment for type 1 diabetes, the search for a vaccine has to be the boldest. But how would you develop such a vaccine, and how would it work?
With Type 2 diabetes emerging as an epidemic, primary care clinicians need to become savvy at initiating and adjusting insulin. Given the nationwide shortage of endocrinologists, referring all patients on insulin for endocrine appointments is not realistic in most areas of the country.
The polls are open for voting for new members of the AADE board, AADE officers, and the nominating committee. The good news is that you can vote for three people! Diabetes Health wishes Board of Directors candidates and former DH Guest Editors, Jane Jeffrie Seley, Kim Higgins, and Deborah Greenwood, the best of luck.
Diabetes educators and their supporters nationwide are being asked to rally behind congressional legislation that would establish a "national diabetes report card," promote better training of doctors with regard to reporting diabetes as a factor in births and deaths, and set federal standards requiring doctors to achieve a level of diabetes education before they can be licensed or certified.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.